StockData
Natures Sunshine Products Inc logo

Natures Sunshine Products Inc (NATR) stock

NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3057% below fair value
$10.56+0.20 (+1.93%)

Close on Nov 16, 2026Market cap $185.81MP/E 10.5Yield –

Natures Sunshine Products EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Natures Sunshine Products's EV/EBITDA was 2.3× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 2.3× to 10.3×, with a median of 5.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.3×−5.2
2025Dec 31, 20257.5×+1.8
2024Dec 31, 20245.8×−3.2
2023Dec 29, 20239.0×+5.4
2022Dec 30, 20223.5×−3.8
2021Dec 31, 20217.3×+0.9
2020Dec 31, 20206.4×+0.6
2019Dec 31, 20195.8×−2.1
2018Dec 31, 20188.0×−9.0
2017Dec 29, 201717.0×+3.8
2016Dec 30, 201613.2×+4.3
2015Dec 31, 20158.8×+0.4
2014Dec 31, 20148.5×+2.4
2013Dec 31, 20136.1×+2.2
2012Dec 31, 20123.9×−6.9
2011Dec 30, 201110.8×+4.6
2010Dec 31, 20106.1×–

More Natures Sunshine Products figures

See a number that looks wrong?